A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
30 septembre 2026 | Kristen V. Brown
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
